Valeo Financial Advisors LLC Sells 408 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Valeo Financial Advisors LLC reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 32.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 859 shares of the company’s stock after selling 408 shares during the quarter. Valeo Financial Advisors LLC’s holdings in HCA Healthcare were worth $232,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. RB Capital Management LLC boosted its stake in shares of HCA Healthcare by 25.9% in the 1st quarter. RB Capital Management LLC now owns 2,432 shares of the company’s stock worth $610,000 after buying an additional 501 shares during the last quarter. American Century Companies Inc. increased its holdings in HCA Healthcare by 18.6% during the first quarter. American Century Companies Inc. now owns 11,035 shares of the company’s stock worth $2,766,000 after buying an additional 1,730 shares during the last quarter. Prudential PLC purchased a new position in HCA Healthcare in the first quarter valued at about $1,083,000. Cetera Investment Advisers raised its holdings in shares of HCA Healthcare by 1.3% in the 1st quarter. Cetera Investment Advisers now owns 4,499 shares of the company’s stock worth $1,128,000 after purchasing an additional 56 shares during the period. Finally, Sequoia Financial Advisors LLC bought a new position in HCA Healthcare during the first quarter valued at $248,000. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 3,861 shares of the firm’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the completion of the transaction, the senior vice president now directly owns 15,899 shares in the company, valued at $4,880,993. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 3,861 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the completion of the sale, the senior vice president now directly owns 15,899 shares in the company, valued at approximately $4,880,993. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Sammie S. Mosier sold 1,645 shares of the stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $312.00, for a total transaction of $513,240.00. Following the sale, the senior vice president now owns 7,646 shares in the company, valued at approximately $2,385,552. The disclosure for this sale can be found here. Insiders sold a total of 14,840 shares of company stock valued at $4,588,869 in the last 90 days. Corporate insiders own 1.70% of the company’s stock.

HCA Healthcare Trading Down 0.1 %

Shares of HCA opened at $322.54 on Tuesday. The firm’s 50-day moving average price is $320.01 and its 200-day moving average price is $280.13. The company has a current ratio of 1.18, a quick ratio of 1.02 and a debt-to-equity ratio of 35.07. The firm has a market capitalization of $85.31 billion, a price-to-earnings ratio of 16.99, a PEG ratio of 1.62 and a beta of 1.65. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $335.83.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, beating the consensus estimate of $5.05 by $0.85. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The company had revenue of $17.30 billion for the quarter, compared to analyst estimates of $16.51 billion. During the same period in the previous year, the company posted $4.64 earnings per share. The firm’s revenue was up 11.7% on a year-over-year basis. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 20.49 EPS for the current year.

HCA Healthcare declared that its board has authorized a stock repurchase plan on Tuesday, January 30th that permits the company to buyback $6.00 billion in outstanding shares. This buyback authorization permits the company to purchase up to 7.4% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s board of directors believes its shares are undervalued.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were given a $0.66 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.60. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date of this dividend was Thursday, March 14th. HCA Healthcare’s payout ratio is currently 13.91%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a report on Wednesday, April 10th. Raymond James boosted their target price on shares of HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Wells Fargo & Company increased their price objective on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a report on Thursday, March 28th. Truist Financial upped their target price on HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a research note on Wednesday, January 31st. Finally, Oppenheimer restated an “outperform” rating and issued a $315.00 price objective on shares of HCA Healthcare in a research report on Wednesday, January 17th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $314.05.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.